As per the post published on patentdocs, by Mr. Sherri Oslick,
Earlier this week, Impax Laboratories, Inc. and Medicis Pharmaceutical Corp. announced that they have entered a Joint Development Agreement and a Settlement and License Agreement that brings to an end their pending lawsuit over Impax's plans to manufacture a generic version of Medics' Solodyn............
The details can be read here.
No comments:
Post a Comment